Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Anavex Life Sciences Reports Grant Of US Patent Covering Blarcamesine (ANAVEX2-73) For Treatment Of Neurodevelopmental Disorders

Author: Benzinga Newsdesk | January 08, 2024 08:51am

The company was granted new U.S. Patent No. 11,839,600 entitled "NEURODEVELOPMENTAL DISORDER THERAPY" from the United States Patent and Trademark Office (USPTO) for its patent application number 17/890,083.

Posted In: AVXL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist